Abstract
Generally speaking, we cannot fully understand the mechanisms of general anesthesia until the molecular mechanisms of consciousness are fully elucidated. Loss of consciousness induced by general anesthetics might involve sensation, motor activity, behavior, memory and self-consciousness. The effects of many anesthetics are not limited to humans but also extend to the animals. Similar levels of minimum anesthetic concentrations are required to induce anesthesia in animals and human, i.e., the minimum alveolar concentration (MAC). Such similarity probably reflects identical anesthetic target molecules and functional conservation based on gene conservation. Thus, to study the mechanisms of anesthetic action, various animal models that are accessible to genetic manipulation, such as nematodes (Caenorhabditis elegans), fruit flies (Drosophila) and mice can be used. Genetic techniques allow for the rapid identification and characterization of genes involved in the actions of general anesthetics. In this review, I will describe the genetic mutations and putative target genes of general anesthetics.
Current Drug Targets
Title: Studies on Target Genes of General Anesthetics
Volume: 3 Issue: 1
Author(s): Sumiko Gamo
Affiliation:
Abstract: Generally speaking, we cannot fully understand the mechanisms of general anesthesia until the molecular mechanisms of consciousness are fully elucidated. Loss of consciousness induced by general anesthetics might involve sensation, motor activity, behavior, memory and self-consciousness. The effects of many anesthetics are not limited to humans but also extend to the animals. Similar levels of minimum anesthetic concentrations are required to induce anesthesia in animals and human, i.e., the minimum alveolar concentration (MAC). Such similarity probably reflects identical anesthetic target molecules and functional conservation based on gene conservation. Thus, to study the mechanisms of anesthetic action, various animal models that are accessible to genetic manipulation, such as nematodes (Caenorhabditis elegans), fruit flies (Drosophila) and mice can be used. Genetic techniques allow for the rapid identification and characterization of genes involved in the actions of general anesthetics. In this review, I will describe the genetic mutations and putative target genes of general anesthetics.
Export Options
About this article
Cite this article as:
Sumiko Gamo , Studies on Target Genes of General Anesthetics, Current Drug Targets 2002; 3 (1) . https://dx.doi.org/10.2174/1389450023348118
DOI https://dx.doi.org/10.2174/1389450023348118 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
GABAB Receptors as Potential Therapeutic Targets
Current Drug Targets - CNS & Neurological Disorders Meet Our Editorial Board Member:
Current Neuropharmacology SPECT Radiopharmaceuticals for Dementia
Current Radiopharmaceuticals A Very Rare Cerebral Complication of Chemotherapy in a Young Girl: A Difficult Diagnosis
Current Drug Safety Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
Current Medicinal Chemistry Current Use of mTOR Inhibitors for the Treatment of Subependymal Giant Cell Astrocytomas and Epilepsy in Patients with TSC
Current Medicinal Chemistry Recent Advancement in Computer-Aided Drug Design
Current Pharmaceutical Design Disruption of Glutamate-Glutamine-GABA Cycle Significantly Impacts on Suicidal Behaviour: Survey of the Literature and Own Findings on Glutamine Synthetase.
CNS & Neurological Disorders - Drug Targets Assessing Glutamatergic Function and Dysfunction in Peripheral Tissues
Current Medicinal Chemistry Adult Neurogenesis in Epileptogenesis: An Update for Preclinical Finding and Potential Clinical Translation
Current Neuropharmacology Patient’s Perceptions of the Cannabis-psychosis Link - A Systematic Review
Current Pharmaceutical Design Exploring the Role of “Brahmi” (Bacopa monnieri and Centella asiatica) in Brain Function and Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Hypersensitivity to Lamotrigine and Nonaromatic Anticonvulsant Drugs: A Review
Current Pharmaceutical Design Recent Approaches for Studying the Role of Glia
CNS & Neurological Disorders - Drug Targets Neuroimaging of Cancer Patients for Psychosocial Support and Patient Care
Current Medical Imaging Metabotropic Glutamate Receptors in Central Nervous System Diseases
Current Drug Targets Editorial (Hot Topic: Organic Solute Transporters and Diseases: Potential Therapeutic Targets)
Current Molecular Pharmacology Tools in the Design of Therapeutic Drugs for CNS Disorders: An up-to-date Review
Current Molecular Pharmacology Natural Products Based Ayurvedic Formulations: Chemical Cons tituents and Treatment in Neurodegenerative Disordersǂ
Mini-Reviews in Organic Chemistry Antipsychotic Medication Adherence and Satisfaction Among Palestinian People with Schizophrenia
Current Clinical Pharmacology